Patents by Inventor Kathleen Reape

Kathleen Reape has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
    Patent number: 8288342
    Abstract: The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate and a package comprising a plurality of dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate.
    Type: Grant
    Filed: October 12, 2009
    Date of Patent: October 16, 2012
    Assignee: Teva Women's Health, Inc.
    Inventors: Salah U. Ahmed, Sundeep Sethia, Kathleen Reape, Howard Hait, Carole S. Ben-Maimon
  • Methods for Treating Vasomotor Symptoms in Castrated Prostatic Cancer Patients with Low Dose Cyproterone Acetate
    Publication number: 20100260860
    Abstract: The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate and a package comprising a plurality of dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate.
    Type: Application
    Filed: October 12, 2009
    Publication date: October 14, 2010
    Inventors: Salah U. AHMED, Sundeep Sethia, Kathleen Reape, Howard Hait, Carole S. Ben-Maimon
  • Methods of Step-Down Hormone Treatment
    Publication number: 20090163454
    Abstract: The present invention relates to methods of step-down hormone treatment in which an estrogen and progestin combination regimen is administered for one or more cycles prior to administration of a lower dose hormone regimen containing a lower daily dosage amount of estrogen and/or progestin.
    Type: Application
    Filed: December 22, 2008
    Publication date: June 25, 2009
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Howard Hait, Kathleen Reape
  • Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
    Publication number: 20070111975
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Application
    Filed: October 30, 2006
    Publication date: May 17, 2007
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Charles Diliberti, Kathleen Reape, Lance Bronnenkant
  • Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
    Publication number: 20060135496
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Application
    Filed: October 7, 2005
    Publication date: June 22, 2006
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Charles DiLiberti, Kathleen Reape, Lance Bronnenkant
  • Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
    Publication number: 20050143359
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: July 16, 2004
    Publication date: June 30, 2005
    Inventors: Robert Bell, Carole Ben-Maimon, Beata Iskold, Lance Bronnenkant, Howard Hait, Kathleen Reape